Entero Therapeutics, Inc.
(NASDAQ CM: ENTO)
Rigrodsky Law, P.A. is investigating Entero Therapeutics, Inc. (“Entero”) regarding possible breaches of fiduciary duties and other violations of law related to Entero’s agreement to merge with Journey Therapeutics, Inc.